Burning Rock Biotech Limited Cost of Revenue
Burning Rock Biotech Limited (BNR) reported Cost of Revenue of CNY 136.65 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-28.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-04-28
CNY
| Period end | Cost of Revenue 6 month | Cost of Revenue 12 month |
|---|---|---|
| 2025-12-31 | 136.65M CNY 20-F · filed 2026-04-28 | |
| 2024-12-31 | 153.42M CNY 20-F · filed 2026-04-28 | |
| 2023-12-31 | 174.21M CNY 20-F · filed 2026-04-28 | |
| 2022-12-31 | 183.20M CNY 20-F · filed 2025-04-29 | |
| 2022-06-30 | 96.19M CNY 6-K · filed 2022-11-07 | |
| 2021-12-31 | 143.72M CNY 20-F · filed 2024-04-29 | |
| 2021-06-30 | 66.73M CNY 6-K · filed 2022-11-07 | |
| 2020-12-31 | 115.98M CNY 20-F · filed 2023-04-20 | |
| 2019-12-31 | 108.34M CNY 20-F · filed 2022-04-29 | |
| 2018-12-31 | 73.81M CNY 20-F · filed 2021-03-23 |
USD
| Period end | Cost of Revenue 6 month | Cost of Revenue 12 month |
|---|---|---|
| 2025-12-31 | $19.54M 20-F · filed 2026-04-28 | |
| 2024-12-31 | $21.02M 20-F · filed 2025-04-29 | |
| 2023-12-31 | $24.54M 20-F · filed 2024-04-29 | |
| 2022-12-31 | $26.56M 20-F · filed 2023-04-20 | |
| 2022-06-30 | $14.36M 6-K · filed 2022-11-07 | |
| 2021-12-31 | $22.55M 20-F · filed 2022-04-29 | |
| 2020-12-31 | $17.77M 20-F · filed 2021-03-23 |